Ask a Librarian

Threre are lots of ways to contact a librarian. Choose what works best for you.

HOURS TODAY

Reference Desk

CONTACT US BY PHONE

(802) 656-2022

Voice

(802) 503-1703

Text

MAKE AN APPOINTMENT OR EMAIL A QUESTION

Schedule an Appointment

Meet with a librarian or subject specialist for in-depth help.

Email a Librarian

Submit a question for reply by e-mail.

WANT TO TALK TO SOMEONE RIGHT AWAY?

Library Hours for Wednesday, May 8th

All of the hours for today can be found below. We look forward to seeing you in the library.
HOURS TODAY
8:00 am - 12:00 am
MAIN LIBRARY

SEE ALL LIBRARY HOURS
WITHIN HOWE LIBRARY

MapsM-Th by appointment, email govdocs@uvm.edu

Media Services8:00 am - 7:00 pm

Reference DeskTBD

OTHER DEPARTMENTS

Special Collections10:00 am - 6:00 pm

Dana Health Sciences Library7:30 am - 11:00 pm

 

CATQuest

Search the UVM Libraries' collections

UVM Theses and Dissertations

Browse by Department
Format:
Online
Author:
Shields, Ryan Thomas
Dept./Program:
Pharmacology
Year:
2022
Degree:
M.S.
Abstract:
Detrusor muscle overactivity in the bladder wall is the hallmark symptom of overactive bladder syndrome and the principal target of therapy that seeks to reduce incontinence and urinary urgency. However, these interventions typically fail to alleviate long-term detrusor overactivity and simply mask the underlying pathology while also potentially introducing undesirable side effects that disrupt quality of life. One alternative mechanism driving of overactive bladder is attributed to ischemia within the bladder, which is subject to enormous swings in pressure and tension on its vasculature restricting blood flow. This observation, coupled with the fact that healthy vascular tissue within the bladder lacks a myogenic response to increasing intraluminal pressures, provides a potential pathological explanation and new therapeutic targets for managing overactive bladder. We evaluated whether conscious voiding behavior in mice is impacted with the introduction of myogenic tone into the bladder vasculature via knock out of the inward-rectifier potassium channel, KIR2.1. The voiding activity of 10 smooth muscle-specific tamoxifen-inducible KIR2.1 knockout mice were observed pre- and post-tamoxifen treatment using the UroVoid System: a novel apparatus for measuring micturition events in real time. A consistent difference of voiding behavior between knockout and control treatment groups could not be demonstrated. However, voiding frequency of all mice within the trials are elevated above established literature values as well as prior trials of different mice within the UroVoid. Absent controls and potential confounding factors from the environment in which the trials take place obscured a definitive conclusion from the data while emphasizing the importance of comprehensive environmental vetting and strict protocol adherence prior to conducting UroVoid experiments. Thus, future experiments can still effectively test the role of KIR2.1 channels in bladder health as long as the confounding factors are accounted for.